Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis.
作者信息
Frew John W, Murrell Dedee F
机构信息
Department of Dermatology, St George Hospital, and University of New South Wales, Sydney, NSW, Australia.
出版信息
Skin Appendage Disord. 2017 Oct;3(4):179-181. doi: 10.1159/000464140. Epub 2017 Apr 29.
Abstract
摘要
相似文献
1
Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis.
Skin Appendage Disord. 2017 Oct;3(4):179-181. doi: 10.1159/000464140. Epub 2017 Apr 29.
2
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937. doi: 10.1177/2050313X231160937. eCollection 2023.
3
The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
J Cutan Med Surg. 2019 Jul/Aug;23(4):428-435. doi: 10.1177/1203475419836435. Epub 2019 Apr 2.
4
Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
J Dermatolog Treat. 2018;29(sup1):3-5. doi: 10.1080/09546634.2018.1527993.
5
Acrodermatitis continua of hallopeau successfully treated with adalimumab.
J Clin Aesthet Dermatol. 2012 Feb;5(2):60-2.
6
Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
J Am Acad Dermatol. 1984 Oct;11(4 Pt 2):755-62. doi: 10.1016/s0190-9622(84)80157-7.
7
Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
SAGE Open Med Case Rep. 2023 Jun 14;11:2050313X231180775. doi: 10.1177/2050313X231180775. eCollection 2023.
8
Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
J Dermatol. 2014 Nov;41(11):1006-8. doi: 10.1111/1346-8138.12639.
9
Squamous cell carcinoma mimicking acrodermatitis continua suppurativa in a patient with generalized pustular psoriasis.
J Dtsch Dermatol Ges. 2023 May;21(5):537-539. doi: 10.1111/ddg.15013. Epub 2023 Mar 24.
10
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Dermatol Ther. 2019 May;32(3):e12899. doi: 10.1111/dth.12899. Epub 2019 Apr 29.
引用本文的文献
1
Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
Clin Cosmet Investig Dermatol. 2023 Apr 6;16:951-957. doi: 10.2147/CCID.S404860. eCollection 2023.
2
Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.
Biologics. 2019 May 20;13:83-87. doi: 10.2147/BTT.S199100. eCollection 2019.
本文引用的文献
1
Secukinumab for Acrodermatitis Continua of Hallopeau.
JAMA Dermatol. 2017 Apr 1;153(4):336-337. doi: 10.1001/jamadermatol.2016.5059.
2
Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
J Dermatol. 2013 Sep;40(9):749-51. doi: 10.1111/1346-8138.12227. Epub 2013 Jul 9.
3
Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
Dermatology. 2013;226(1):28-31. doi: 10.1159/000346572. Epub 2013 Feb 15.
4
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
Arch Dermatol. 2012 Mar;148(3):297-9. doi: 10.1001/archdermatol.2011.2473.
5
Acrodermatitis continua of Hallopeau: evolution of treatment options.
Int J Dermatol. 2011 Oct;50(10):1195-211. doi: 10.1111/j.1365-4632.2011.04993.x.
6
Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.
N Engl J Med. 2011 Aug 18;365(7):620-8. doi: 10.1056/NEJMoa1013068.
7
Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
J Eur Acad Dermatol Venereol. 2009 Jun;23(6):707-8. doi: 10.1111/j.1468-3083.2008.02998.x. Epub 2008 Sep 9.
Zotero 插件